FDA Inspection
Baxalta US Inc.Baxalta US Inc. – FDA Inspection, Jan 17, 2020
Record Details
This FDA Inspection record concerns Baxalta US Inc., with an inspection on January 17, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Baxalta US Inc.
- Inspection Date
- January 17, 2020
- Product Type
- Biologics
View Company Profile
ID · 1e6d6d48-82cf-4812-9ae5-37c4ede74bed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118072
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Baxalta US Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | Not classified | Los Angeles District Office | Blood and Blood Products |
| April 7, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 10, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxalta US Inc.
- FDA Inspection 1279237 - 2025-09-18
- FDA Inspection 1166545 - 2022-04-07
- FDA Inspection 1038757 - 2018-01-19
- FDA Inspection 972505 - 2016-03-10
- FDA Inspection 870344 - 2014-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.